Polymorphisms in XPD and ERCC1 Associated with Colorectal Cancer Outcome.

作者: Ming-Yii Huang , Jaw-Yuan Wang , Meng-Lin Huang , Hui-Jen Chang , Shiu-Ru Lin

DOI: 10.3390/IJMS14024121

关键词: Epidermal growth factor receptorXeroderma pigmentosumGenotypeInternal medicineDNA repairMedicinePathologyOncologyNucleotide excision repairColorectal cancerERCC1Disease

摘要: Using the comprehensive approach to selecting polymorphisms date, we sought examine whether recurrence in colorectal cancer was associated with inherited variation three genes involved DNA repair and cell proliferation. Three polymorphisms, which are excision cross-complementation 1 (ERCC1), xeroderma pigmentosum group D (XPD) epidermal growth factor receptor (EGFR), were assessed 257 postoperative stage II/III CRC patients 5-fluorouracial chemotherapy Taiwan. In addition, correlations between genetic patients’ clinicopathological features investigated. Genotypes of XPD codon751 A/A ERCC1 codon118 T/T regional a statistically significant way (p = 0.018). Patients who carried AA TT genotypes demonstrated significantly greater risk (OR 5.625, 95% CI, 1.557–20.32). Inherited outcome As association single-nucleotide has not been studied previously cancer, these findings suggest novel sites variation, part explaining range treatment responses seen this disease.

参考文章(39)
Francesco Graziano, Annamaria Ruzzo, Fotios Loupakis, Emanuele Canestrari, Daniele Santini, Vincenzo Catalano, Renato Bisonni, Umberto Torresi, Irene Floriani, Gaia Schiavon, Francesca Andreoni, Paolo Maltese, Eliana Rulli, Bostjan Humar, Alfredo Falcone, Lucio Giustini, Giuseppe Tonini, Andrea Fontana, Gianluca Masi, Mauro Magnani, Pharmacogenetic Profiling for Cetuximab Plus Irinotecan Therapy in Patients With Refractory Advanced Colorectal Cancer Journal of Clinical Oncology. ,vol. 26, pp. 1427- 1434 ,(2008) , 10.1200/JCO.2007.12.4602
Andrew McVean, Simon Kent, Alexei Bakanov, Tom Hobbs, Rhona Anderson, Development and validation of 'AutoRIF': software for the automated analysis of radiation-induced foci Genome Integrity. ,vol. 3, pp. 1- 13 ,(2012) , 10.1186/2041-9414-3-1
Annamaria Ruzzo, Francesco Graziano, Fotios Loupakis, Eliana Rulli, Emanuele Canestrari, Daniele Santini, Vincenzo Catalano, Rita Ficarelli, Paolo Maltese, Renato Bisonni, Gianluca Masi, Gaia Schiavon, Paolo Giordani, Lucio Giustini, Alfredo Falcone, Giuseppe Tonini, Rosarita Silva, Rodolfo Mattioli, Irene Floriani, Mauro Magnani, Pharmacogenetic Profiling in Patients With Advanced Colorectal Cancer Treated With First-Line FOLFOX-4 Chemotherapy Journal of Clinical Oncology. ,vol. 25, pp. 1247- 1254 ,(2007) , 10.1200/JCO.2006.08.1844
Jeffrey A. Meyerhardt, Denise Heseltine, Donna Niedzwiecki, Donna Hollis, Leonard B. Saltz, Robert J. Mayer, James Thomas, Heidi Nelson, Renaud Whittom, Alexander Hantel, Richard L. Schilsky, Charles S. Fuchs, Impact of Physical Activity on Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From CALGB 89803 Journal of Clinical Oncology. ,vol. 24, pp. 3535- 3541 ,(2006) , 10.1200/JCO.2006.06.0863
Michael J O'Connell, Megan E Campbell, Richard M Goldberg, Axel Grothey, Jean-François Seitz, Jacqueline K Benedetti, Thierry André, Daniel G Haller, Daniel J Sargent, None, Survival Following Recurrence in Stage II and III Colon Cancer: Findings From the ACCENT Data Set Journal of Clinical Oncology. ,vol. 26, pp. 2336- 2341 ,(2008) , 10.1200/JCO.2007.15.8261
M.Y. Huang, M.J. Chen, H.L. Tsai, C.H. Kuo, C.J. Ma, M.F. Hou, S.C. Chuang, S.R. Lin, J.Y. Wang, Prospective analysis of KRAS wild-type patients with metastatic colorectal cancer using cetuximab plus FOLFIRI or FOLFOX4 treatment regimens. Genetics and Molecular Research. ,vol. 10, pp. 3002- 3012 ,(2011) , 10.4238/2011.OCTOBER.3.4
Yue-zu Fan, Guo-feng Zhang, Zhan-xia Li, Zhi-qian Hu, [Expression of lymphatic vessel endothelial hyaluronan receptor-1 in human colorectal cancer and its clinical significance]. Chinese Journal of Gastrointestinal Surgery. ,vol. 12, pp. 511- 514 ,(2009) , 10.3760/CMA.J.ISSN.1671-0274.2009.05.027
Hai-tao Xu, Yan-long Liu, Xin-shu Dong, Yan-mei Yang, Time pattern and prognostic evaluation of the recurrence of rectal cancer after resection Chinese journal of surgery. ,vol. 47, pp. 102- 105 ,(2009) , 10.3760/CMA.J.ISSN.0529-5815.2009.02.009
L. H. Sobin, International Union Against Cancer TNM Classification of Malignant Tumours. pp. 19- 56 ,(2002)
Andrea Bonetti, Marta Zaninelli, Emilia Durante, Anna Paola Fraccon, Tiziano Franceschi, Felice Pasini, Fable Zustovich, Silvano Brienza, Multiple-target chemotherapy (LV-modulated 5-FU bolus and continuous infusion, oxaliplatin, CPT- 11) in advanced 5-FU-refractory colorectal cancer: MTD definition and efficacy evaluation. A phase I-II study. Tumori. ,vol. 92, pp. 389- 395 ,(2006) , 10.1177/030089160609200504